Document is current
Any future updates will be listed below
-
Authors
Pearson, Joseph J.
Chiou, Gennifer
Rahman, Mikayla L.
Gonzalez, Grecia
Bizios, Rena
Ong, Joo L.
Guda, Teja https://orcid.org/0000-0002-3218-2916
-
Funding
Funding for this research was provided by:
National Institute of Dental and Craniofacial Research (R01DE025286)
Division of Chemical, Bioengineering, Environmental, and Transport Systems (1847103)
University of Texas at San Antonio
National Institutes of Health (GM060655)
- License Information
-
More Information
Article History
Received: 1 September 2024
Accepted: 10 February 2025
First Online: 16 April 2025
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose related to any of the data presented in this study.
: There was no in vivo work and IACUC approval is not pertinent to the current study. Similarly, no clinical/patient samples were involved in this study and as such IRB oversight is not pertinent to this study.
: No primary animal or human tissue was used in this study and the study was exempt from institutional review board review. The human bone-marrow-derived mesenchymal stem cells (MSCs) cell line: PCS-500-012™, with certification were purchased from ATCC, Manassas, VA and validated for stemness using differentiation protocols from the same manufacturer, and used at passage 3 as detailed in the manuscript.
: No research ethics committee’s approval was required to accomplish the goals of this study and no specific informed consent was applicable.
